Osmetech wins 510(k) for thrombophilia diagnostic; St. Jude increased revenue by cutting jobs;

> Osmetech won FDA 510(k) clearance for its eSensor diagnostic for thrombophilia, a hereditary condition involving a propensity to develop blood clots. Report

> Chinese medical devices producer Golden Meditech established a joint venture, Golden Meditech Information Management (China), with renowned U.S. government medical insurance management firms SynerMed and EHS, in Shanghai, the financial hub of China. Story

> St. Jude Medical, which last year chose to cut medical device jobs, has shared that its first quarter results reflect the benefit of its restructuring. The company reported net sales of $1.262 billion in the first quarter of 2010, an increase of 11 percent compared with the first quarter of 2009. Report

> Cardiovascular Systems, has received FDA unconditional investigational device exemption approval to proceed with ORBIT II, a pivotal trial to evaluate the safety and effectiveness of its Diamondback 360 System in the coronary arteries. Release

> With support from the EU Commission, GE Healthcare and a group of 10 medical device manufacturers within the European Coordination Committee of the Radiological, Electromedical and Healthcare IT industry have committed to a self-regulatory initiative to reduce the average energy consumption of new ultrasound products by 25 percent by 2012. Release

> The use of a mobile compression device for the prevention of thromboembolic disease after total hip arthroplasty is likely just as effective as low-molecular-weight heparin treatment but safer, according to a study in the March issue of the Journal of Bone & Joint SurgeryReport

> Congressman Erik Paulsen (R-MN), co-chair of the House Medical Technology Caucus, introduced a bill, the Defend Medical Innovation Act, to overturn a $20 billion excise tax on medical device companies included in the health reform bills. Item

And Finally... An occupational therapist is pioneering a new "virtual" method to analyze movement patterns in children--and more effectively treat those with debilitating motor disorders. Report

Suggested Articles

Takeda tapped Roche’s Foundation Medicine to develop tissue- and blood-based companion diagnostic tests for its portfolio of lung cancer therapies.

Cellex has announced plans to develop a rapid coronavirus test that people can fully perform at home, from sample collection to result, using an app.

More than 20 states either don’t release or have incomplete data on the rapid antigen tests now considered key to containing the coronavirus.